Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 463899

Therapeutic problem solving: a systematic approach.

R Sorkness
View original source ↗Export metadata ↓

Abstract

A systematic approach to therapeutic problem solving is discussed. Therapeutic problem solving includes defining the problem, assessing possible solutions to the problem and choosing the best solution (therapy). The thought processes specific to drug therapy include: (1) choice of agent, (2) evaluation of benefit versus risk ratios, and (3) determination of dosage. Once treatment has been initiated, the problem-solving process shifts to reassessing the patient, monitoring and readjusting therapy, and anticipating new problems related to therapy. An algorithm is provided to demonstrate a thought sequence for solving therapeutic problems. To assure that no important consideration has been neglected, it is useful to develop a pattern of thought that may be applied to each therapeutic situation.

Explore related subjects

Drug Administration ScheduleDrug TherapyHumansModels, TheoreticalPharmacyProblem SolvingSystems AnalysisJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Sorkness. 1979. Therapeutic problem solving: a systematic approach.. https://pubmed.ncbi.nlm.nih.gov/463899/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.

OBJECTIVES: To describe the effects of low dose hormonal replacement therapy (LD-HRT) on quality of life in early postmenopausal women, since the postmenopausal estrogen deprivation in mid age women often brings along a series of changes and symptoms, which may greatly affect quality of life. METHODS: Fifty normal postmenopausal women were recruited and randomly treated with LD-HRT, 17beta-estradiol (1 mg/day) and norethisterone acetate (0.5 mg/day) (LD-HRT) or calcium supplement (controls). No significant differences in age, age at menopause, the presence of chronic diseases and socio-economic status were present in the two groups. The Women's Health Questionnaire (WHQ), a validated quality-of-life instrument for perimenopausal and postmenopausal women, was administered at baseline and after 6 and 12 weeks of treatment in both groups. RESULTS: At baseline no significant differences in WHQ scores were present in the two groups. In the control group the scores in all different areas showed no significant modification either after 6 and 12 weeks of observation. Conversely, the LD-HRT group showed a significant decrease in the scores of vasomotor symptoms, somatic symptoms, anxiety/fear, depressed mood and sleep problem items. No effects on memory/concentration and menstrual symptoms areas were evident. CONCLUSION: Although quality of life is also and may be mainly influenced by socio-economic and cultural factors, LD-HRT definitively can improve not only vasomotor symptoms, but also more general aspects of physical and psychological well-being of symptomatic postmenopausal women.

Drug Administration Schedule↗